Schedule 13D ownership disclosure

Anchiano Therapeutics Ltd.

Security class unavailable · CUSIP: 03280X102

Event date: 2019-02-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
40.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-047113
Form type
SC 13D
Filer
Access Industries Holdings LLC
CIK
CIK 1391297
Filed
Feb 21, 2019
Reporting period
Feb 14, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub